Skip to main content
Premium Trial:

Request an Annual Quote

Fluxergy Nabs CE-IVD Mark for SARS-CoV-2 POC PCR Test

NEW YORK – Diagnostic startup Fluxergy announced on Thursday that its COVID-19 RT-PCR test has received CE-IVD marking.

The Irvine, California-based company's automated, sample-to-answer Fluxergy Diagnostic Testing System has the ability to run multiple different assay types at the same time, such as molecular, immunochemistry, cytometry, and chemistry tests, on the same cartridge. The Fluxergy COVID-19 Sample-to-Answer-RT-PCR test returns results in one hour.

The firm is now seeking commercial partnerships with healthcare providers and "potential international go-to-market partners in Europe, Asia, and Australia," CCO Ali Tinazli said in a statement. The company has expanded manufacturing capabilities for the testing system to 1 million tests per month, it said in a statement.

Fluxergy had previously made its platform available for research use only with its partners, including University of California, San Diego and Mass General Brigham.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.